This brand name is authorized in Estonia
The drug ROTOP-MDP contains one active pharmaceutical ingredient (API):
|
1
Technetium ⁹⁹ᵐTc medronic acid
UNII X89XV46R07 - TECHNETIUM TC-99M MEDRONATE
|
|
Technetium Tc 99m medronic acid is a pharmaceutical product used in nuclear medicine imaging. Technetium Tc 99m medronic acid may be used as a bone imaging agent to delineate areas of altered osteogenesis. It is composed of a technetium ion complexed with medronic acid, a type of bisphosphonate. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09BA02 | Technetium (99mTc) medronic acid | V Various → V09 Diagnostic radiopharmaceuticals → V09B Skeleton → V09BA Technetium (99mTc) compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1414224 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
